Ilyang Bio Simvastatin Tablet
Simvastatin 20mg
Tablet · Prescription medication
Ilyang Biopharm Co., Ltd.
MFDS item code 200503786 · Notified 2005.12.30
This product's status changed to Expired on 2024.10.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hyperlipidemia (including familial hyperlipidemia in children) and prevention of cardiovascular disease
This medication helps reduce the risk of cardiovascular diseases. It lowers the risk of cardiac mortality, myocardial infarction, and stroke in adult patients with a history of coronary artery disease, diabetes, peripheral vascular disease, or stroke. It also reduces the risk associated with coronary and non-coronary vascular procedures. In the treatment of dyslipidemia, it controls cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia and improves cardiovascular health by increasing HDL cholesterol. In particular, it is used to improve blood lipids in pediatric patients with familial heterozygous hypercholesterolemia in conjunction with dietary therapy. This medication is effectively used for the prevention of cardiovascular diseases and the treatment of dyslipidemia.
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Risk reduction in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. Administration of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose appropriately based on the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and regularly thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of this medicine at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or more without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) See below for recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, administer 40 mg of this medicine once daily in the evening to patients with homozygous familial hypercholesterolemia. Use this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or if other lipid-lowering treatments are not available. (2) In elderly patients, the maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is administered concomitantly to patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is administered concomitantly to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day. (5) Concomitant administration with other lipid-lowering agents This medicine is effective when used alone or concomitantly with bile acid sequestrants. When this medicine is administered concomitantly with fibrates (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. (6) Administration to patients with renal impairment As this medicine is not extensively excreted by the kidneys, dose adjustment is not required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg once daily and monitor closely.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, with a recommended maximum dose of 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goals. Allow an interval of 4 weeks or more between dose adjustments.
This medication may cause muscle-related disorders such as myopathy or rhabdomyolysis. The risk increases especially when taking high doses, so caution is necessary. People with allergies to this medication or its components, those with liver diseases or elevated liver function test results, pregnant women or women with the potential for pregnancy, and nursing mothers should not take this medication. Additionally, when taken with certain potent drugs, the risk of muscle damage may increase, so the dosage should be adjusted to a lower dose or another medication should be substituted if taking drugs that interact with this medication. People who consume large amounts of alcohol, have liver or kidney problems, have a history of hypothyroidism or muscle disorders, the elderly, and women should be particularly cautious when taking this medication. During treatment, if there is unexplained muscle pain, tenderness, or weakness, promptly inform a doctor, and if necessary, discontinue the medication. Regular liver function tests should be conducted before and during treatment, as there may be liver function abnormalities, and if symptoms such as hepatitis or jaundice occur, consult medical personnel immediately. Pregnant women or those planning to become pregnant should not take this medication, and if pregnancy is confirmed during treatment, it should be stopped immediately and a doctor consulted. This medication can be used in children and adolescents, but it should not be administered to children under 10 years of age or to females before menarche. This medication can interact with several other drugs, so individuals taking other medications should inform their doctor or pharmacist, and it is advisable to avoid certain foods such as grapefruit juice. In case of overdose, general emergency measures should be taken, and it should be stored out of the reach of children in its original container.
Myopathy, rhabdomyolysis, abdominal pain, weakness, constipation, diarrhea, dyspepsia, bloating, nausea, headache, upper respiratory infection, edema, atrial fibrillation, gastritis, diabetes, myalgia, insomnia, dizziness, bronchitis, sinusitis, eczema, urinary tract infection, muscle cramps, arthralgia, taste disturbance, ocular movement disorder, facial incomplete paralysis, tremor, sensory disturbance, peripheral neuropathy, peripheral nerve paralysis, mental disorder, anxiety, sleep disturbance, nightmares, depression, severe muscle weakness, ocular muscle weakness, anaphylaxis, angioedema, lupus erythematosus-like syndrome, polymyositis, dermatomyositis, vasculitis, purpura, thrombocytopenia, leukopenia, hemolytic anemia, positive antinuclear antibodies, increased erythrocyte sedimentation rate, eosinophilia, arthritis, urticaria, photosensitivity, fever, chills, flushing, fatigue, dyspnea, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, pancreatitis, hepatitis, liver failure, cholestasis jaundice, hepatic fat changes, liver cirrhosis, fulminant liver necrosis, liver cancer, loss of appetite, vomiting, alopecia, pruritus, skin changes, lichen planus-like drug rash, gynecomastia, reduced libido, erectile dysfunction, cataract progression, ocular muscle paralysis, anemia, elevated aminotransferases, elevated ALP, elevated γ-GTP, elevated bilirubin levels, thyroid dysfunction, elevated serum creatine kinase, abnormal liver function tests, increased HbA1c, increased fasting blood glucose levels, elevated serum aminotransferase levels, persistent elevation of serum aminotransferase levels, thrombocytopenia, interstitial lung disease, sensory numbness in limbs, paresthesia, cold sensation, muscle weakness
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. The recommended storage temperature is room temperature between 1°C and 30°C. This helps to maintain the medication's efficacy and safety for a longer time.
Brownish-yellow oval film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Simvastatin 20mg
Tablet · Prescription medication
Ilyang Biopharm Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.